MJP Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$250K Sell
2,887
-7,263
-72% -$696K 0.03% 193
2025
Q4
$975K Sell
10,150
-475
-4% -$46.1K 0.12% 69
2025
Q3
$1.01M Buy
10,625
+784
+8% +$72.1K 0.13% 65
2025
Q2
$858K Buy
9,841
+627
+7% +$53.2K 0.13% 71
2025
Q1
$828K Buy
9,214
+2,463
+36% +$220K 0.15% 70
2024
Q4
$539K Buy
+6,751
New +$584K 0.1% 96

Other funds holding MDT

MJP Associates's MDT Position: Q1 2026 in Review

MJP Associates reduced its Medtronic (MDT) stake by 72% in Q1 2026, selling an estimated $696K and leaving 2,887 shares worth $250K. The position accounts for 0.03% of the portfolio, ranked #193.

MJP Associates first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.01M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • MJP Associates held 2,887 shares of Medtronic worth $250K as of Q1 2026.
  • MJP Associates sold 7,263 Medtronic shares in Q1 2026, an estimated $696K.
  • Medtronic made up 0.03% of MJP Associates's portfolio in Q1 2026, its #193 holding.
  • MJP Associates first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • MJP Associates's Medtronic position peaked at $1.01M in Q3 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.